WuXi PharmaTech (Cayman), Inc. (ADR) (NYSE:WX)

CAPS Rating: 4 out of 5

China-based pharmaceutical and biotechnology R&D outsourcing company which provides a integrated portfolio of laboratory and manufacturing services in the drug discovery and development process to pharmaceutical and biotechnology companies.

Recs

0
Player Avatar TMFBreakerThiel (85.74) Submitted: 1/13/2009 4:35:04 PM : Outperform Start Price: $7.00 WX Score: +51.39

I like the CRO business (contract research...not drug development, as some seem to think) as a secular trend, and WuXi is the lower-cost Chinese solution. Perhaps not the greatest business moat, but at this price, I'll take the risk.

Featured Broker Partners


Advertisement